| |
|
|
|
Catalyst Biosciences Inc.  
|
|
5.71 -0.43 (-0.07%) |
02-27 16:00 |
|
Open: |
5.91 |
Pre close: |
6.14 |
Target:
|
8.95 
|
|
High: |
5.91 |
Low: |
5.6 |
Resistance:
|
7.66
8.94
|
|
Volume: |
475,165 |
Market Cap: |
99M |
Support:
|
5.60
4.66
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.30
|
MACD |
MACD(12,26):
|
-0.23 |
|
MA(20): |
7.11 |
Signal(12,26,9): |
-0.03 |
|
MA(100): |
6.14 |
Stochastic Oscillator |
%K(14,3):
|
4.26 |
|
MA(250): |
7.16 |
%D(3): |
7.94 |
|
Average Volume(K) |
3-Month: |
65110
|
52-Week |
High:
|
10.84 |
|
10-Days: |
70039 |
Low: |
4.52 |
|
RSI |
RSI(14):
|
35.19 |
Change(%): |
-35.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-4.370 |
Return on Equity (ttm) |
-49.6 |
Shares Out. (M) |
12.04 |
|
EPS Est. Current Year |
-7.910 |
Return on Assets (ttm) |
-30.5 |
Shares Float (M) |
7.02 |
|
EPS Est. Next Year |
-4.810 |
PEG Ratio |
0.07 |
% Held by Insiders |
7.84 |
|
EPS Est. Next Quarter |
-1.550 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
69.57 |
|
Forward EPS |
-4.863 |
Gross Profit (p.s.) |
-1.783 |
Shares Short (K) |
561 |
|
Book Value (p.s.) |
6.760 |
EBITDA (p.s.) |
-4.545 |
P/E |
-1.31 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.84 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-44.53 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-26.41 |
P/CF |
-1.54 |
|
|
|
|
|
|
